Bausch & Lomb Corp — Director's Dealing 2023

Jun 12, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bausch & Lomb Corp (BLCO)
CIK: 0001860742
Period of Report: 2023-06-01

Reporting Person: Bonnefoy Luc (President,Surgical)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, No Par Value	39368	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Options (right to purchase)	$18.00		Common Shares (83956)		Direct
Non-Qualified Stock Options (right to purchase)	$17.96		Common Shares (19676)		Direct

Footnotes

F1: Reflects (i) an award of 21,222 restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") granted on May 5, 2022 which is generally scheduled to vest 50% on the second anniversary of the grant date and 50% on the third anniversary of the date of grant or, if later, the earlier of Bausch + Lomb Corporation's (the "Issuer") full separation from Bausch Health Companies, Inc. ("BHC") or a change in control of the Issuer, (ii) an award of 12,000 RSUs under the Plan granted on August 2, 2022 which is generally scheduled to vest 1/3rd on each of the first three anniversaries of the date of grant and (iii) an award of 6,146 RSUs under the Plan granted on March 1, 2023 which is generally scheduled to vest 1/3rd on each of the first three anniversaries of the date of grant, in each case subject to the terms of the Plan and the applicable award agreement and continued employment through the applicable vesting date.

F2: (continued from footnote 1) Vested RSUs are settled in common shares, no par value ("Common Shares"), of the Issuer.

F3: Reflects an award of stock options to purchase Common Shares granted under the Plan on May 5, 2022. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date or, if later, upon the full separation from BHC or a change in control of the Issuer, subject to the terms of the Plan and the applicable award agreement and continued employment through the applicable vesting date.

F4: Reflects an award of stock options to purchase Common Shares granted under the Plan on March 1, 2023. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.

F5: The stock options will expire on the tenth anniversary of the grant date.